For the year ending 2025-12-31, RMTG has $4,488,694 in assets. $39,233,729 in debts. $956,718 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 956,718 | |||
| Accounts receivable | 43,815 | |||
| Inventory | 159,277 | |||
| Prepaid expenses | 62,950 | |||
| Total current assets | 1,222,760 | |||
| Property and equipment, net | 870,759 | |||
| Other assets | 32,538 | |||
| Intangible assets | 487,700 | |||
| Less accumulated amortization | 426,236 | |||
| Intangible assets, net | 61,464 | |||
| Right of use asset, net | 621,195 | |||
| Goodwill | 1,679,978 | |||
| Total assets | 4,488,694 | |||
| Accounts payable and accrued liabilities | 348,394 | |||
| Accrued interest | 16,559,277 | |||
| Customer advances | 351,193 | |||
| Derivative liability | 2,406,552 | |||
| Lease liability | 219,973 | |||
| Convertible notes payable, net | 47,452 | |||
| Notes payable-related parties | 7,800 | |||
| Notes payable, net | 16,883,979 | |||
| Total current liabilities | 36,824,620 | |||
| Lease liability, net of current portion | 409,110 | |||
| Notes payable, net of current portion | 1,999,999 | |||
| Total liabilities | 39,233,729 | |||
| Preferred stock, value-Series APreferred Stock | 1,050 | |||
| Preferred stock, value-Series CPreferred Stock | 1 | |||
| Preferred stock, value-Series DPreferred Stock | 10 | |||
| Common stock, 0.001 par value 100,000,000 shares authorized 13,138,968 and 12,538,968 issued and outstanding for the years ended december 31, 2025, and december 31, 2024, respectively | 13,139 | |||
| Additional paid in capital | 40,606,276 | |||
| Accumulated deficit | -75,365,511 | |||
| Total stockholders deficit | -34,745,035 | |||
| Total liabilities and stockholders deficit | 4,488,694 | |||
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)